Zobrazeno 1 - 10
of 54
pro vyhledávání: '"Jessica A, Hellings"'
Publikováno v:
Disabilities, Vol 4, Iss 2, Pp 277-289 (2024)
(1) Background: Psychiatrists are increasingly required to treat minimally verbal (MV) individuals with autism spectrum disorder (ASD), intellectual disability (ID) and behavior problems without much published guidance. (2) Methods: We reviewed 80 ch
Externí odkaz:
https://doaj.org/article/aa26bd277b8c4eb19a2ebfc9f49de993
Publikováno v:
Archives of Sexual Behavior. 52:1339-1343
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::81dd3def95996ffebf53bd98878a9c88
https://doi.org/10.1007/s10508-022-02443-z
https://doi.org/10.1007/s10508-022-02443-z
Autor:
Natasha Marrus, Kathleen A Koth, Jessica A Hellings, Rachel McDonald, McLeod Frampton Gwynette, Rebecca Muhle, William D Lohr, Roma A Vasa
Publikováno v:
Autism : the international journal of research and practice.
Autism spectrum disorder and intellectual disability are associated with psychiatric comorbidities, yet a 2009 study of US child and adolescent psychiatry program directors indicated that psychiatry residents receive insufficient training in autism s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d92fa1ff69ec46efb132d25efaf57bc
https://pubmed.ncbi.nlm.nih.gov/35920285
https://pubmed.ncbi.nlm.nih.gov/35920285
Autor:
W David Lohr, Jessica A. Hellings, M Frampton Gwynette, Rebecca Muhle, Roma A. Vasa, Kathleen A Koth, Aacap Autism, Natasha Marrus
Publikováno v:
Journal of the American Academy of Child & Adolescent Psychiatry. 61:1-2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::004c8a49efdaa1e3cd74ed11a0c3d85e
https://doi.org/10.1016/j.jaac.2021.09.397
https://doi.org/10.1016/j.jaac.2021.09.397
Autor:
Jessica A. Hellings, Kathleen A. Koth, William David Lohr, Natasha Marrus, McLeod F. Gwynette, Roma A. Vasa, Rebecca Muhle, Meera Rothman
Publikováno v:
Journal of the American Academy of Child & Adolescent Psychiatry. 60:S160-S161
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6ecf6bf38c94f807c5a61ce2ea2f3224
https://doi.org/10.1016/j.jaac.2021.09.082
https://doi.org/10.1016/j.jaac.2021.09.082
Publikováno v:
Journal of the American Academy of Child & Adolescent Psychiatry. 60:S185
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5538949c573bd36071124e5404c1f846
https://doi.org/10.1016/j.jaac.2021.09.157
https://doi.org/10.1016/j.jaac.2021.09.157
Publikováno v:
Expert Opinion on Pharmacotherapy. 18:581-588
Drug development and repurposing are urgently needed for individuals with autism spectrum disorders (ASD) and psychiatric comorbidity, which often presents as aggression and self-injury. Areas covered: We review dopamine antagonists, including classi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff47b5946cf577de8d42b1865a919548
https://doi.org/10.1080/14656566.2017.1308483
https://doi.org/10.1080/14656566.2017.1308483
Publikováno v:
Journal of Autism and Developmental Disorders. 46:1344-1353
Loxapine substitution is a promising option for patients with autism spectrum disorder (ASD) who develop antipsychotic-induced metabolic illness. We performed a chart review of 15 adolescents and adults meeting DSM-IV-TR criteria for ASD, all with an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97ed8175bc6e24f55f5ee0c07144381a
https://doi.org/10.1007/s10803-015-2675-3
https://doi.org/10.1007/s10803-015-2675-3
Autor:
Xueliang Pan, Jill A. Hollway, Kristin A. Buchan-Page, Rameshwari V. Tumuluru, Laura Silverman, Susan L. Hyman, Michael G. Aman, Nicole V. Brown, Robert R. Rice, Benjamin L. Handen, Melissa M. Ryan, Luc Lecavalier, Elizabeth Hurt, Daniel W. Mruzek, Sarah McAuliffe-Bellin, Patricia Corbett-Dick, Jessica A. Hellings, L. Eugene Arnold, Tristram Smith, Lynne Levato
Publikováno v:
Journal of the American Academy of Child & Adolescent Psychiatry. 54:905-915
Objective Impairments associated with attention-deficit/hyperactivity disorder (ADHD) and noncompliance are prevalent in children with autism spectrum disorder (ASD). However, ADHD response to stimulants is well below rates in typically developing ch
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3cef6599d0489ba62d50c0009a3a8a00
https://doi.org/10.1016/j.jaac.2015.08.013
https://doi.org/10.1016/j.jaac.2015.08.013
Publikováno v:
Journal of Child and Adolescent Psychopharmacology. 25:618-624
New and repurposed drugs are urgently needed to treat individuals with autism spectrum disorders (ASD). Loxapine (LOX) in low doses of 5-15 mg/day resembles an atypical antipsychotic (Stahl 2002 ). Our recent open pilot study of LOX found significant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f32cf8749c9258ba3eab02bc35fb19a4
https://doi.org/10.1089/cap.2014.0145
https://doi.org/10.1089/cap.2014.0145